Takeda Pharmaceutical Company Limited Operating Income 2011-2026 | TAK

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income Takeda Pharmaceutical Company Limited

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
509 B	100 B	238 B	242 B	156 B	-	-	-	-	-	-

All numbers in JPY currency

Indicator range from annual reports

Maximum	Minimum	Average
509 B	100 B	249 B

Operating Income of other stocks in the Biotechnology industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-508 M	-	2.43 %	$ 254 M	Germany
Aligos Therapeutics ALGS	-88 M	$ 8.51	6.44 %	$ 84.1 M	USA
AlloVir ALVR	-46.2 M	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	-127 M	-	-	$ 10.1 M	USA
Genfit SA GNFT	31.8 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-26.8 M	-	-13.47 %	$ 169 M	France
Applied Therapeutics APLT	-64.5 M	-	-	$ 8.42 M	USA
Midatech Pharma plc MTP	-7 M	-	-18.52 %	$ 27.3 M	Britain
BioNTech SE BNTX	15.3 B	$ 97.45	2.04 %	$ 27.2 B	Germany
Amphastar Pharmaceuticals AMPH	140 M	$ 20.73	1.74 %	$ 969 M	USA
Acorda Therapeutics ACOR	-265 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	-139 M	-	-	$ 86.2 M	USA
Advaxis ADXS	-36.3 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-8.67 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-24 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-210 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	23.5 M	$ 1.42	1.42 %	$ 365 M	USA
Applied Genetic Technologies Corporation AGTC	-17.7 M	-	-	$ 26.5 M	USA
Allakos ALLK	-196 M	-	-	$ 28.6 M	USA
Aptinyx APTX	-62.6 M	-	-39.0 %	$ 4.57 M	USA
Can-Fite BioPharma Ltd. CANF	-9.95 M	$ 2.91	-0.34 %	$ 4.79 M	Israel
Aquestive Therapeutics AQST	-71.1 M	$ 4.16	1.84 %	$ 445 M	USA
Aravive ARAV	-70.8 M	-	-13.39 %	$ 1.45 M	USA
Arcutis Biotherapeutics ARQT	-12.2 M	$ 23.99	-0.91 %	$ 3.05 B	USA
AIkido Pharma AIKI	-55.7 M	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	-287 M	$ 32.25	0.03 %	$ 2.14 B	USA
Autolus Therapeutics plc AUTL	-271 M	$ 1.48	-1.01 %	$ 394 M	Britain
Cidara Therapeutics CDTX	-176 M	-	-	$ 1.41 B	USA
AVROBIO AVRO	10.2 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	-37.5 M	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	-7.83 M	$ 2.58	1.12 %	$ 16.2 M	USA
AstraZeneca PLC AZN	1.06 B	-	-	$ 96.9 B	Britain
Akero Therapeutics AKRO	-285 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	-412 M	-	-	$ 867 M	Germany
Brainstorm Cell Therapeutics BCLI	-9.95 M	-	-2.5 %	$ 5.88 M	USA
BeiGene, Ltd. BGNE	447 M	-	0.49 %	$ 251 B	Cayman-islands
Akouos AKUS	-86.8 M	-	0.23 %	$ 488 M	USA
Akari Therapeutics, Plc AKTX	-17.3 M	$ 3.79	-0.98 %	$ 255 B	Britain
Allena Pharmaceuticals ALNA	-47.6 M	-	3.16 %	$ 1.9 M	USA
Baudax Bio BXRX	-56.8 M	-	0.59 %	$ 63 K	USA
Cabaletta Bio CABA	-172 M	$ 3.19	1.76 %	$ 321 M	USA
Alpine Immune Sciences ALPN	-58.1 M	-	-	$ 2.17 B	USA
CymaBay Therapeutics CBAY	-102 M	-	-	$ 3.45 B	USA
Aileron Therapeutics ALRN	-50.6 M	-	10.36 %	$ 9.8 M	USA